• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Yo 副肿瘤性小脑变性中的遗传改变和肿瘤免疫攻击。

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

机构信息

Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France.

French Reference Center on Paraneoplastic Neurological Syndrome, Hospices civils de Lyon, Lyon, France.

出版信息

Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.

DOI:10.1007/s00401-017-1802-y
PMID:29299667
Abstract

Paraneoplastic cerebellar degenerations with anti-Yo antibodies (Yo-PCD) are rare syndromes caused by an auto-immune response against neuronal antigens (Ags) expressed by tumor cells. However, the mechanisms responsible for such immune tolerance breakdown are unknown. We characterized 26 ovarian carcinomas associated with Yo-PCD for their tumor immune contexture and genetic status of the 2 onconeural Yo-Ags, CDR2 and CDR2L. Yo-PCD tumors differed from the 116 control tumors by more abundant T and B cells infiltration occasionally organized in tertiary lymphoid structures harboring CDR2L protein deposits. Immune cells are mainly in the vicinity of apoptotic tumor cells, revealing tumor immune attack. Moreover, contrary to un-selected ovarian carcinomas, 65% of our Yo-PCD tumors presented at least one somatic mutation in Yo-Ags, with a predominance of missense mutations. Recurrent gains of the CDR2L gene with tumor protein overexpression were also present in 59% of Yo-PCD patients. Overall, each Yo-PCD ovarian carcinomas carried at least one genetic alteration of Yo-Ags. These data demonstrate an association between massive infiltration of Yo-PCD tumors by activated immune effector cells and recurrent gains and/or mutations in autoantigen-encoding genes, suggesting that genetic alterations in tumor cells trigger immune tolerance breakdown and initiation of the auto-immune disease.

摘要

抗 Yo 抗体相关副肿瘤性小脑变性 (Yo-PCD) 是由肿瘤细胞表达的神经元抗原 (Ags) 引起的自身免疫反应引起的罕见综合征。然而,导致这种免疫耐受破坏的机制尚不清楚。我们对 26 例与 Yo-PCD 相关的卵巢癌进行了研究,分析了它们的肿瘤免疫微环境以及 2 个神经肿瘤 Yo-Ags(CDR2 和 CDR2L)的遗传状态。与 116 例对照肿瘤相比,Yo-PCD 肿瘤的 T 细胞和 B 细胞浸润更为丰富,偶尔会形成含有 CDR2L 蛋白沉积的三级淋巴结构。免疫细胞主要存在于凋亡的肿瘤细胞附近,表明存在肿瘤免疫攻击。此外,与非选择性卵巢癌不同,我们研究的 Yo-PCD 肿瘤中有 65%至少存在 1 个 Yo-Ags 的体细胞突变,且主要为错义突变。在 59%的 Yo-PCD 患者中还存在 CDR2L 基因的反复获得和/或肿瘤蛋白过表达。总体而言,每个 Yo-PCD 卵巢癌都至少存在一个 Yo-Ags 的遗传改变。这些数据表明,Yo-PCD 肿瘤中激活的免疫效应细胞的大量浸润与自身抗原编码基因的反复获得和/或突变之间存在关联,提示肿瘤细胞的遗传改变触发了免疫耐受破坏和自身免疫疾病的发生。

相似文献

1
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.Yo 副肿瘤性小脑变性中的遗传改变和肿瘤免疫攻击。
Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.
2
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.抗 Yo 抗体相关副肿瘤性小脑变性卵巢癌的转录组免疫特征分析。
Br J Cancer. 2018 Jul;119(1):105-113. doi: 10.1038/s41416-018-0125-7. Epub 2018 Jun 14.
3
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.小脑变性相关蛋白2和2样蛋白在有或没有Yo抗体的卵巢癌患者中均有存在。
Cancer Immunol Immunother. 2017 Nov;66(11):1463-1471. doi: 10.1007/s00262-017-2041-8. Epub 2017 Jul 14.
4
CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration.CDR2L抗体:副肿瘤性小脑变性中的新角色
PLoS One. 2013 Jun 18;8(6):e66002. doi: 10.1371/journal.pone.0066002. Print 2013.
5
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.乳腺癌的免疫和遗传特征引发抗 Yo 相关副肿瘤性小脑变性。
Neurol Neuroimmunol Neuroinflamm. 2022 Jul 12;9(5). doi: 10.1212/NXI.0000000000200015. Print 2022 Sep.
6
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.副肿瘤性小脑变性:Yo 抗体改变线粒体钙缓冲能力。
Neuropathol Appl Neurobiol. 2019 Feb;45(2):141-156. doi: 10.1111/nan.12492. Epub 2018 May 24.
7
A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.基于小脑退行性变相关蛋白 2 样细胞的抗 Yo 检测在副肿瘤性小脑变性患者中的应用。
Eur J Neurol. 2023 Jun;30(6):1727-1733. doi: 10.1111/ene.15786. Epub 2023 Mar 26.
8
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration.CDR2L 是副肿瘤性小脑变性中主要的 Yo 抗体靶标。
Ann Neurol. 2019 Aug;86(2):316-321. doi: 10.1002/ana.25511. Epub 2019 Jun 13.
9
Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.抗-Yo 相关副肿瘤性小脑变性患者乳腺癌中人类表皮生长因子受体 2 的过表达。
Neuro Oncol. 2012 Apr;14(4):506-10. doi: 10.1093/neuonc/nos006. Epub 2012 Feb 20.
10
Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.免疫性副肿瘤性小脑变性的基础与治疗意义。
Front Immunol. 2020 Jun 2;11:991. doi: 10.3389/fimmu.2020.00991. eCollection 2020.

引用本文的文献

1
Autoimmune encephalitis.自身免疫性脑炎
Nat Rev Dis Primers. 2025 Sep 11;11(1):65. doi: 10.1038/s41572-025-00650-1.
2
Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications.癌症中的神经-免疫相互作用:机制与治疗意义
Signal Transduct Target Ther. 2025 Jun 2;10(1):176. doi: 10.1038/s41392-025-02241-8.
3
Mechanisms of autoimmune-mediated paraneoplastic syndromes: immune tolerance and disease pathogenesis.自身免疫介导的副肿瘤综合征的机制:免疫耐受与疾病发病机制。
Front Immunol. 2025 May 9;16:1608934. doi: 10.3389/fimmu.2025.1608934. eCollection 2025.
4
Case Report: Anti-Yo antibody mediated paraneoplastic cerebellar degeneration in a patient with squamous cell lung carcinoma.病例报告:一名鳞状细胞肺癌患者中抗Yo抗体介导的副肿瘤性小脑变性。
Front Immunol. 2025 Mar 21;16:1558867. doi: 10.3389/fimmu.2025.1558867. eCollection 2025.
5
Paraneoplastic Neurologic Syndrome Associated with Fallopian Tube Cancer: A Case Report.与输卵管癌相关的副肿瘤性神经系统综合征:一例报告
Case Rep Oncol. 2025 Jan 6;18(1):35-41. doi: 10.1159/000542885. eCollection 2025 Jan-Dec.
6
Breast Cancer Specificities of Patients With Anti-Ri Paraneoplastic Neurologic Syndromes.抗Ri副肿瘤性神经综合征患者的乳腺癌特异性
Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200367. doi: 10.1212/NXI.0000000000200367. Epub 2025 Jan 17.
7
Roles of CDR2 and CDR2L in Anti-Yo Paraneoplastic Cerebellar Degeneration: A Literature Review.CDR2和CDR2L在抗Yo副肿瘤性小脑变性中的作用:文献综述
Int J Mol Sci. 2024 Dec 25;26(1):70. doi: 10.3390/ijms26010070.
8
Case report: paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab.病例报告:与抗Yo抗体相关的副肿瘤性小脑变性经奥法木单抗成功治疗
Front Immunol. 2024 Dec 16;15:1476397. doi: 10.3389/fimmu.2024.1476397. eCollection 2024.
9
Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration.副肿瘤性小脑变性患者的外泌体微小RNA谱改变
Ann Clin Transl Neurol. 2024 Dec;11(12):3255-3266. doi: 10.1002/acn3.52232. Epub 2024 Oct 29.
10
Blood-Brain Barrier Disruption in Neuroimmunological Disease.神经免疫性疾病中的血脑屏障破坏。
Int J Mol Sci. 2024 Oct 2;25(19):10625. doi: 10.3390/ijms251910625.